From above results, we can conclude that the improvement of glucose uptake and transport in the brain may be the pathway by which SZL exerts its neuroprotective effect, and the potential molecular mechanism may be related to the normalization of the insulin signal transduction pathway InR/PI3K/Akt in early AD. This evidence concerns the gene INS and Alzheimer disease.